Skip to main content
SpringerLink
Log in

GM2 Gangliosidosis

  • Chapter
Magnetic Resonance of Myelin, Myelination, and Myelin Disorders

  • 125 Accesses

Abstract

GM2 gangliosidoses are inherited disorders involving sphingolipid storage. There are three major, biochemically distinct types: B, O, and AB. Type B is the classical Tay-Sachs disease (TSD) and type O is equivalent to Sandhoff’s disease (SD).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • BĂ©rard-Badier M, Paillias JE, Gastaut H, Edgar GWF (1958) Essai sur la signification des dĂ©myĂ©linisations dans l’idiotie amaurotique infantile. Psychiatry Neurol 132: 50–93

    Article  Google Scholar 

  • Brett EM, Ellis RB, Haas L, Ikonne JU, et al. (1973) Late onset GM2-gangliosidosis: Clinical, pathological and biochemical studies on 8 patients. Arch Dis Child 48: 775–785

    Article  PubMed  CAS  Google Scholar 

  • Burg J, Banerjee A, Sandhoff K (1985) Molecular forms of GM2-activator protein. Biol Chem Hoppe Seyler 366: 887–891

    Article  PubMed  CAS  Google Scholar 

  • Cantor RM, Lim JST, Roy C, Kaback MM (1985) Sandhoff disease heterozygote detection: A component of population screening for Tay-Sachs disease carriers. I. Statistical methods. Am J Hum Genet 37: 912–921

    Google Scholar 

  • Charrow J, Binns HJ (1986) Ganglioside loading of cultured fibroblasts: A provocative method for the diagnosis of the GM2 gangliosidoses. Clin Chim Acta 156: 41–50

    Article  PubMed  CAS  Google Scholar 

  • Conzelmann E, Kytzia HJ, Navon R, Sandhoff K (1983) Ganglioside GM, N-acetyl-Ăź-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM, gangliosidosis patients and of healthy probands with low hexosaminidase level. Am J Hum Genet 35: 900–913

    Google Scholar 

  • Conzelmann E, Sandhoff K (1978) AB variant of infantile GM, gangliosidosis: Deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2. Proc Natl Acad Sci USA 75: 3979–3983

    Article  PubMed  CAS  Google Scholar 

  • D’azzo A, Proia RL, Koldny EH, Kaback MM (1984) Faulty association of a-and f-subunits in some forms of /i-hexosaminidase A deficiency. J Biol Chem 259: 11070–11 074

    Google Scholar 

  • Di Gregorio F, Ferrari G, Marini P, Siliprandi R, et al. (1984) The influence of gangliosides on neurite growth and regeneration. Neuropediatrics 15: 93–96

    Article  PubMed  Google Scholar 

  • Fardeau M, Lapresle J (1963) Maladie de Tay-Sachs avec atteinte importante de la substance blanche. A propos de deux observations anatomo-cliniques. Rev Neurol Paris 109: 157–175

    Google Scholar 

  • Goebel HH (1984) Morphology of the gangliosidoses. Neuropediatrics 15: 97–106

    Article  PubMed  Google Scholar 

  • Goldie WD, Holtzman D, Suzuki K (1977) Chronic Hexo- saminidase A and B deficiency. Ann Neurol 2: 156–158

    Article  Google Scholar 

  • Gordon BA, Gordon KE, Hinton GG, Cadera W, et al. (1988) Tay-Sachs disease: B1 variant. Pediatr Neurol 4: 54–57

    Article  PubMed  CAS  Google Scholar 

  • Grabowski GA, Kruse JR, Goldberg JD, Chokkalingam K, et al. (1984) First-trimester prenatal diagnosis of Tay-Sachs disease. Am J Hum Genet 36: 1369–1378

    PubMed  CAS  Google Scholar 

  • Grabowski GA, Willner JP, Bender A, Gordon RE, et al. (1980) Chronic /-hexosaminidase a deficiency - clinical and biochemical studies of a new neuromuscular disease. Pediatr Res 14: 632

    Google Scholar 

  • Grebner EE, Mansfield DA, Raghavan SS, Kolodny EH, et al. (1986) Two abnormalities of hexosaminidase A in clinically normal individuals. Am J Hum Genet 38: 505–515

    PubMed  CAS  Google Scholar 

  • Hirabayashi Y, Li YT, Li SC (1983) The protein activator specific for the enzymic hydrolysis of GM, ganglioside in normal human brain and brains of three types of GM2 gangliosidosis. J Neurochem 40: 168–175

    Article  PubMed  CAS  Google Scholar 

  • Inui K, Grebner EE, Jackson LG, Wenger DA, Juvenile GM, gangliosidosis (AMB variant): Inability to activate hexosaminidase A by activator protein. Am J Hum Genet 35: 551–564

    Google Scholar 

  • Inui K, Yutaka T, Okada S, Yabuuchi H, et al. (1985) Hexosaminidase A activity in skin fibroblasts from various types of GM, gangliosidosis using a fluorogenic sulphated substrate. J Inherited Metab Dis 8: 149–150

    Article  PubMed  CAS  Google Scholar 

  • Johnson WG, Chutorian A, Miranda A (1977) A new juvenile hexosaminidase deficiency disease presenting as cerebellar ataxia. Neurology 27: 1012–1018

    Article  PubMed  CAS  Google Scholar 

  • Koeslag JH, Schach SR, Melzer CW (1984) Tay-Sachs disease and the persistence of lethal autosomal recessive genes in human populations. S Afr Med J 66: 87–89

    PubMed  CAS  Google Scholar 

  • Kotagal S (1986) Diagnosis of AB variant, GM2 gangliosidosis. Ann Neurol 19: 102

    Article  PubMed  CAS  Google Scholar 

  • Kotagal S, Wenger DA, Alcala H, Gomez C, et al. (1986) AB variant GM, gangliosidosis: Cerebrospinal fluid and neuropathologie characteristics. Neurology 36: 438–440

    CAS  Google Scholar 

  • Kytzia HJ, Hinrichs U, Sandhoff K (1984) Diagnosis of infantile and juvenile forms of GM2 gangliosidosis variant 0. Residual activities toward natural and different synthetic substrates. Hum Genet 67: 414–418

    Article  PubMed  CAS  Google Scholar 

  • Li SC, Serizawa S, Li YT, Nakamura K, et al. (1984) Effect of modification of sialic acid on enzymic hydrolysis of gangliosides GM, and GM2. J Biol Chem 259: 5409–5410

    Google Scholar 

  • Li YT, Hirabayashi Y, Li SC (1983) Differentiation of two variants of type-AB GM2 gangliosidosis using chromogenic substrates. Am J Hum Genet 35: 520–522

    Google Scholar 

  • MacLeod PM, Wood S, Jan JE, Applegarth DA, et al. (1977) Progressive cerebellar ataxia, spasticity, psychomotor retardation, and hexosaminidase deficiency in a 10-year-old child: Juvenile Sandhoff disease. Neurology 27: 571–573 Meek D, Wolfe LS, Andermann E, Andermann F (1984) Juvenile progressive dystonia: A new phenotype of GM2 Gangliosidosis. Ann Neurol 15: 348–352

    Google Scholar 

  • Myerowitz R, Hogikyan ND (1986) Different mutations in Ashkenazi Jewish and Non-Jewish French Canadians with Tay-Sachs disease. Science 232: 1646–1648

    Article  PubMed  CAS  Google Scholar 

  • Navon R, Argov Z, Brand N, Sandbunk U (1981) Adult GM2 gangliosidosis in association with Tay-Sachs disease: A new phenotype. Neurology 31: 1397–1401

    Google Scholar 

  • O’Brien JS (1970) Generalized gangliosidosis. In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology, vol 10. Amsterdam: North Holland Publishing Company: 462–483

    Google Scholar 

  • O’Brien JS, Okada S, Chen A, Fillerup DL (1970) Tay-Sachs disease: Detection of heterozygotes and homozygotes by serum hexosaminidase assay. N Engl J Med 283: 15–20

    Google Scholar 

  • O’Brien JS (1978) Suggestions for a nomenclature for the GM2 gangliosidoses making certain (possibly unwarrantable) assumptions. Am J Hum Genet 30: 672–675

    PubMed  Google Scholar 

  • Oates CE, Bosch E, Hart MN (1986) Movement disorders associated with chronic GM2 gangliosidosis. Eur Neurol 25: 154–159

    Article  PubMed  CAS  Google Scholar 

  • Oonk JGW, Helm van der HJ, Martin JJ (1979) Spinocerebellar degeneration: Hexosaminidase A and B deficiency in two adult sisters. Neurology 29: 380–384

    Google Scholar 

  • Pampiglione G, Harden A (1984) Neurophysiological investigations in GMT and GM2 gangliosidoses. Neuropediatrics 15: 74–84

    Article  PubMed  Google Scholar 

  • Paritzky JF (1985) Tay-Sachs. The dreaded inheritance. Am J Nurs 85: 260–264

    Article  PubMed  CAS  Google Scholar 

  • Pergament E, Ginsberg N, Verlinsky Y, Cadkin A, et al. (1983) Prenatal Tay-Sachs diagnosis by chorionic villi sampling. Lancet II: 286

    Google Scholar 

  • Pullarkat RK, Reha H, Beratis NG (1981) Accumulation of ganglioside GM2 in cerebrospinal fluid of a patient with the variant AB of infantile GM2 gangliosidosis. Pediatrics 68: 106–108

    PubMed  CAS  Google Scholar 

  • Rapin I, Suzuki K, Suzuki K, Valsamis MP (1976) Adult (chronic) GM2 gangliosidosis. Arch Neurol 33: 120–130

    Article  PubMed  CAS  Google Scholar 

  • Sandhoff K, Conzelmann E (1984) The biochemical basis of gangliosidoses. Neuropediatrics 15: 85–92

    Article  PubMed  CAS  Google Scholar 

  • Sandhoff K, Harzer K, Waessle W, Jatzkewitz H (1971) Enzyme alterations and lipid storage in three variants of Tay-Sachs disease. J Neurochem 18: 2469–2489

    Article  PubMed  CAS  Google Scholar 

  • Schulte FJ (1984) Clinical course of GM, gangliosidoses. A correlative attempt. Neuropediatrics 15: 66–70

    Article  PubMed  Google Scholar 

  • Schwab ME, Vassella F (1984) Synopsis: Gangliosidoses. Neuropediatrics 15: 107–109

    Google Scholar 

  • Sonderfeld S, Brendler S, Sandhoff K, Galjaard H, et al. (1985) Genetic complementation in somatic cell hybrids of four variants of infantile GM2 gangliosidosis. Hum Genet 71: 196–200

    Article  PubMed  CAS  Google Scholar 

  • Sonderfeld S, Conzelmann E, Schwarzmann G, Burg J, et al. (1985) Incorporation and metabolism of ganglioside GM, in skin fibroblasts from normal and GM2 gangliosidosis subjects. Eur J Biochem 149: 247–255

    Article  PubMed  CAS  Google Scholar 

  • Steele MW (1980) Lessons from the American Tay-Sachs programme. Lancet II: 914

    Google Scholar 

  • Thieffry S, Bertrand I, Bargeton E, Edgar GWF, et al. (1960) Idiotie amaurotique infantile avec altĂ©rations graves de la substance blanche. Rev Neurol 102: 130–152

    PubMed  CAS  Google Scholar 

  • Volk BW, Schneck L, Adachi M (1970) Clinic, pathology and biochemistry of Tay-Sachs disease. In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology, vol 10. Amsterdam: North Holland Publishing Company: 385–426

    Google Scholar 

  • Willner JP, Grabowski GA, Gordon RE, Bender AN, et al. (1981) Chronic GM2 gangliosidosis masquerading as atypical Friedreich ataxia: Clinical, morphologic, and biochemical studies of nine cases. Neurology 31: 787–798

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Diagnostic Radiology and Neuroradiology, Free University Hospital, De Boelelaan 1117, NL-1007 MB, Amsterdam, The Netherlands

    Professor Dr. Jacob Valk

  2. Department of Child Neurology, Academic Hospital, Catharijnesingel 101, NL-3511 GV, Utrecht, The Netherlands

    Dr. Marjo S. van der Knaap

Authors
  1. Professor Dr. Jacob Valk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dr. Marjo S. van der Knaap
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Valk, J., van der Knaap, M.S. (1989). GM2 Gangliosidosis. In: Magnetic Resonance of Myelin, Myelination, and Myelin Disorders. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-02568-0_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-02568-0_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-02570-3

  • Online ISBN: 978-3-662-02568-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation